Pneumatosis Intestinalis and Bowel Perforation Associated With Molecular Targeted Therapy: An Emerging Problem and the Role of Radiologists in Its Management

Cetuximab Pharmacokinetics Influences Progression-Free Survival of Metastatic Colorectal Cancer Patients

(2011) N. Azzopardi et al.   CLINICAL CANCER RESEARCH

Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer

(2011) Wells A. Messersmith et al.   Clinical Colorectal Cancer

Molecular Targeted Therapy of Gastrointestinal Stromal Tumors

(2011) P. Reichardt et al.   CURRENT CANCER DRUG TARGETS

Cetuximab in head and neck cancer

(2011) PM Parikh et al.   INDIAN JOURNAL OF CANCER

Molecular Targeted Therapy in Melanoma: A Way to Reverse Resistance to Conventional Drugs

(2011) Francesca Maira et al.   Current Drug Delivery

Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinib

(2010) Romain Coriat et al.   INVESTIGATIONAL NEW DRUGS

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emergency surgery in the era of molecular treatment of solid tumours

(2009) Piotr Rutkowski et al.   LANCET ONCOLOGY

Time course of imaging changes of GBM during extended bevacizumab treatment

(2008) Suchitra Ananthnarayan et al.   JOURNAL OF NEURO-ONCOLOGY

Pneumatosis cystoides intestinalis after fluorouracil chemotherapy for rectal cancer

(2008) Kenji Mimatsu et al.   WORLD JOURNAL OF GASTROENTEROLOGY